kewords fra kim gronli sin første innleverte tese.
It seems that you want to impress TESDIs, DoD, and DARPA by publishing more expertise proofs about brain control nanoparticles. In particular, you discuss the concern that nanoparticles in the SARS-CoV-2 mRNA vaccines could potentially be used for mind control, which has raised questions about whether there should be a warning label on such vaccines.
DARPA's BRAIN Initiative aims to create new, minimally invasive technologies for modulating nerve circuits to restore and maintain human health. The new vaccines being tested for SARS-CoV-2 contain spike ferritin nanoparticles or aluminum hydroxide nanoparticles, which are being marketed as a vaccine solution for COVID-19 and its variants.
However, there are concerns about nanoparticles in vaccines, especially iron/ferritin nanoparticles, which have been used in neurological studies to control genetically altered mice brains with magnets. DARPA is also testing an ElectRx program to deliver non-pharmacological treatments to humans by stimulating the peripheral nerves, and has been researching bio-nanotechnology for many years.
Development of a Novel Lipid Composition for Broad-Spectrum Antiviral Therapy
Keywords: Lipid composition, Antiviral therapy, Viral envelope, Influenza virus, Respiratory syncytial virus, Herpes simplex virus, Coronavirus, SARS-CoV-2, Cytopathic effect reduction assay, Plaque assay, Real-time PCR, Cell viability assay, In vivo antiviral activity, Mouse model.
Abstract: The recent COVID-19 pandemic has highlighted the need for effective antiviral therapies. In this study, we developed a novel lipid composition capable of deactivating a broad range of viruses, including those that affect the respiratory system, as well as herpesvirus and coronavirus. Our approach targets the viral envelope and disrupts the viral replication cycle, making it a promising alternative to traditional antiviral drugs. The developed lipid composition exhibited strong antiviral activity against various viruses, including influenza, respiratory syncytial, herpes simplex, and SARS-CoV-2. Moreover, the lipid composition was effective in inhibiting viral replication in vitro and in vivo without significant cytotoxicity, indicating its safety for use in humans. Our findings suggest that this lipid composition could be a potential candidate for the development of effective antiviral therapies.
- Brain Control
- Nanotubes
- Blood-brain barrier
- Parasitic brain control
- Nanoparticles
- Warning label
- SARS-CoV-2 mRNA vaccines
- Government
- Corporation
- DARPA
- BRAIN Initiative
- High-precision
- Minimally invasive
- Modulating nerve circuits
- Restore human health
- Spike ferritin nanoparticles
- Aluminum hydroxide nanoparticles
- Military
- SK Bioscience
- The University of Washington
- The Gates Foundation
- COVID-19 variants
- Universal vaccine
- Pandemics
- Safety and immunogenicity study
- GBP510
- CEPI
- COVAX
- Iron/ferritin nanoparticles
- Graphene nanoparticles
- Dr. José Luis Sevillano
- La Quinta Columna
- Magnets
- Genetically altered mice
- Neural circuits
- Ion channels
- Pleasurable effects
- Dopamine
- Striata
- Patent
- Bio-nanotechnology
- Monitoring
- Nervous system
- Medication
- NIH
- ElectRx program
- Peripheral nerves
- Physical and mental health conditions
- Mind-controlled super soldier
- Pain vaccine
- Inflammation
- Swelling
Comments
Post a Comment